Zota Health Care Limited will attend an analyst and institutional investor meeting on June 02, 2026, to provide a business update. The meeting is part of Axis Capital’s Rising Stars Conference and will be held at Hotel Grand Hyatt in Mumbai. The company stated that no unpublished price sensitive information will be shared during the interaction.

The meeting format includes both one-on-one and group discussions with analysts and institutional investors. Officials from Zota Health Care Limited will represent the company during the conference.

The business update presentations used in the meeting are already in the public domain and are available on the company’s and stock exchange websites. This ensures transparency and compliance with regulatory norms regarding information disclosure.

The intimation was submitted to The National Stock Exchange of India Limited pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was made by Ashvin Variya, Company Secretary & Compliance Officer.

The following table provides the specific details of the scheduled meeting:

Zota Health Care Limited has reported its audited financial results for the quarter and year ended March 31, 2026, alongside a detailed investor presentation. The company achieved a consolidated revenue of ₹53,865.75 lakhs in FY26, a growth of 83.86% compared to ₹29,297.46 lakhs in the previous year. While revenue surged, the company reported a net loss of ₹7,407.74 lakhs for the fiscal year, widening from ₹5,673.89 lakhs in FY25. The Board of Directors approved the audited standalone and consolidated financial results in a meeting on May 22, 2026.

Q4FY26 & FY26 Financial Highlights

For the quarter ended March 31, 2026, revenue from operations stood at ₹16,317.53 lakhs, while EBITDA was recorded at ₹1,191.17 lakhs. On a year-on-year basis, Q4 revenue grew from ₹973 million to ₹1.6 billion, while the net loss for Q4 widened to ₹145 million compared to a loss of ₹129 million in the same period last year. The Board recommended a final dividend of Re. 1/- per equity share of Rs. 10/- each for the financial year 2025-26, subject to shareholder approval.

The table below summarises the key financial metrics for Q4FY26 and the full year FY26:

Operational Expansion

Zota Health Care significantly expanded its Davaindia network during the fiscal year. The total number of stores reached 2,579 nationwide by the end of March 2026, comprising 1,656 COCO (Company Owned Company Operated) and 923 FOFO (Franchise Owned Franchise Operated) outlets. The company added 997 new stores during FY26, marking the highest store addition in the pharma retail segment in a single financial year. The yearly Gross Merchandise Value (GMV) for the network stood at ₹45,706 lakhs.

Strategic Developments

The company appointed Mr. Mahendra Singh Dhoni and Mr. Suniel Shetty as brand ambassadors for its Davaindia platform. Additionally, Zota Health Care launched a new retail format called "All Day Stores" (ADS) through its subsidiary, Everyday Herbal Beauty Care Limited (EHBCL). To reinforce its backward integration strategy, the company increased its stake in EHBCL to 87.78% by acquiring 1,18,00,000 equity shares via a rights issue for ₹19.47 crore. The Board also approved the acquisition of 39,794 equity shares of Davaindia Health Mart Limited, a wholly-owned subsidiary, for ₹20.19 crore.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE358U01012/b5e489f81fb74700.pdf